XML 36 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
CASH FLOW FROM OPERATING ACTIVITIES    
Net loss $ (1,374,638)us-gaap_NetIncomeLoss $ (504,876)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization 40,156us-gaap_AdjustmentForAmortization 40,156us-gaap_AdjustmentForAmortization
Depreciation 10,284us-gaap_Depreciation 0us-gaap_Depreciation
Stock-based compensation and warrants 91,286us-gaap_ShareBasedCompensation 86,278us-gaap_ShareBasedCompensation
(Increase) decrease in assets    
Prepaid drug product for testing (204,230)us-gaap_IncreaseDecreaseInInventories (197,692)us-gaap_IncreaseDecreaseInInventories
Other current assets (22,142)us-gaap_IncreaseDecreaseInOtherCurrentAssets (93,347)us-gaap_IncreaseDecreaseInOtherCurrentAssets
Increase (decrease) in liabilities    
Accounts payable and accrued expenses 54,253us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 125,059us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Net cash used in operating activities (1,405,031)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (544,422)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
CASH FLOW FROM FINANCING ACTIVITIES    
Net proceeds from sale of common stock 0us-gaap_ProceedsFromIssuanceOfCommonStock 13,812,373us-gaap_ProceedsFromIssuanceOfCommonStock
Net cash from financing activities 0us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 13,812,373us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
NET INCREASE (DECREASE) IN CASH (1,405,031)us-gaap_CashPeriodIncreaseDecrease 13,267,951us-gaap_CashPeriodIncreaseDecrease
Cash, beginning of period 13,858,798us-gaap_Cash 3,551,832us-gaap_Cash
Cash, end of period $ 12,453,767us-gaap_Cash $ 16,819,783us-gaap_Cash